Back to search

Ireland· IE-PA-PA1217/008/002

Levofloxacin 5 mg/ml solution for infusion

A levofloxacin product containing levofloxacin, registered in Ireland by Hikma Farmacêutica (Portugal) S.A.. The same ATC class is registered in 17 of our 19 countries.

ATC J01MA12

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedLevofloxacin 5 mg/ml solution for inf…ATCJ01MA12REGISTER NO.IE-PA-PA1217/008/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Levofloxacin is registered in 17 of 19 countries.

Countries holding a registration under ATC J01MA12 (levofloxacin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Levofloxacin · ATC J01MA12

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levofloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.24 g), the median price runs from $0.68 in Italy to $3.14 in Switzerland — a ×4.6 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levofloxacin · price per daily dose (0.24 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.14
  • IT Italy$0.68
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Levofloxacin
Manufacturer
Hikma Farmacêutica (Portugal) S.A.
Country
Ireland (IE)
ATC code
J01MA12
ATC class
Levofloxacin
Defined daily dose
0.24 g, Inhal
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA1217/008/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

593 interactions on record for levofloxacin.

Graded by severity as the source publishes them — 125 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levofloxacin · interactions on record

593 records

  • 125 severe
  • 341 moderate
  • 52 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PrednisoloneA07EA01severe

75 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levofloxacin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Levofloxacin 1a Pharma, Levofloxacin Actavis
  • Belgium · Levofloxacin Noridem, Levofloxacine Eg
  • Bulgaria · Levofloxacin Kabi, Levor 5 Mg/Ml
  • Cyprus · Amesol, Fairlim
  • Czechia · Levofloxacin Aptapharma, Levofloxacin Kabi
  • Germany · Levoflox, Levofloxacin 1 A Pharma
  • Denmark · Levofloxacin Macure, Levofloxacin Noridem
  • Estonia · Levnibiot, Levofloxacin Basi
  • Spain · Bactyflox, Levofloxacin Sanovel
  • Finland · Levofloxacin Fresenius Kabi, Levofloxacin Krka
  • France · Levofloxacine Accord Healthcare, Levofloxacine Almus
  • United Kingdom (Northern Ireland) · Evoxil, Eyflox
  • Greece · Cinlevo, Evoxil
  • Croatia · Flexid, Fovelid
  • Hungary · Avatac, Leflokin
  • Iceland · Oftaquix, Quinsair
  • Italy · Agilev, Allgram
  • Liechtenstein · Quinsair
  • Lithuania · Levalox, Levofloxacin Actavis
  • Luxembourg · Levofloxacine Eg, Levofloxacine Fresenius Kabi
  • Latvia · Levalox, Levofloxacin Basi
  • Malta · Evoxil, Floxaval
  • Netherlands · Levofloxacin Hemihydrate Aurobindo, Levofloxacine Beximco
  • Norway · Levofloxacin Macure, Levofloxacin Noridem Enterprises
  • Poland · Levalox, Levocin
  • Portugal · Lenovan, Levofloxacina
  • Romania · Cenomar, Fleraday
  • Sweden · Levofloxacin Actavis, Levofloxacin Krka
  • Slovenia · Leviaben, Levofloksacin Aptapharma
  • Slovakia · Levalox, Levofloxacin Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/996ceb08-65fa-479b-bbf4-15cbf3a8295f
GET /v1/drugs/996ceb08-65fa-479b-bbf4-15cbf3a8295f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01MA",
    "J01MA12"
  ],
  "strength": null,
  "pa_number": "PA1217/008/002",
  "substances": [
    "Levofloxacin"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "20/04/2012",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about levofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.